{"id":866193,"date":"2025-07-02T11:52:19","date_gmt":"2025-07-02T15:52:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/"},"modified":"2025-07-02T11:52:19","modified_gmt":"2025-07-02T15:52:19","slug":"hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/","title":{"rendered":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  02, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kNRJCDwc0Ob1mbDWLYLMRoE3wFonhuzsHHrGCIa3VHl7sDE-3kKQoRDQkUw37cbTw2f8inHX-UD917kcrTtStwAKI_ve8lhuvbH6KeNUleP8y28Oyy2Cs44TFb-ILHY2kivEF5Q2a4djxRe7pXrhFkk1KFyySdXYw6VjvcknqlB_WDHD62BOlV16azux5Zds\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a> announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (\u201cHims &amp; Hers\u201d or the \u201cCompany\u201d) securities between April 29, 2025 and June 23, 2025, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>\n        <strong>Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gj59df7UZEfBboBSoI3feMmrYS6VNXZbYlRb8G1kPANOz8a29elk0O0tItEl-EzOrd8ClnwTlciJ97rOswhR4g-cf0aC9rx81zbzaagTq9T4m6VA7PtYVCjuarQAKe2A0U7-9FVPIXNdRNkieEU_6A==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>Firm<\/strong><br \/>\n        <\/a><br \/>\n        <strong> prior to the August 25, 2025 lead plaintiff motion deadline.<\/strong>\n      <\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q9yx-G_lAcGlCnfy5IFplrGoIWMy8-noptyB3Q0s0M2CfE8x3fFfSHA_sqDKdLpR09KuI6_cuX0gXpWWnrDEp3ay9xKjxc6shtE_9FAm4vuUXfz2lpJCJC-BNNbFbHNOvQT_TWrPZqX5H1WyKgHwWLtfIBThf6zvsDrKmJZ_cWhpimTOeyydiN_pYW8q_IvgKm--bKfSF5SGpbmepDnzjQ==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD<\/strong>: April 29, 2025 to June 23, 2025<\/p>\n<p align=\"justify\">\n        <strong>ALLEGATIONS<\/strong>: Hims &amp; Hers is a telehealth company that provides prescription medications, over-the-counter medications, and personal care products.\u00a0 According to the filed complaint, on April 29, 2025, Hims &amp; Hers announced a long-term collaboration with Novo Nordisk A\/S, starting with the immediate sale of <em>\u201ca bundled offering of Novo Nordisk\u2019s FDA-approved Wegovy\u00ae on the Hims &amp; Hers platform.\u201d<\/em><\/p>\n<p align=\"justify\">The\u00a0Hims &amp; Hers\u00a0class action lawsuit alleges that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;text-align:justify\">Hims &amp; Hers was engaged in the <em>\u201cdeceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk<\/em>\u201d; and<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">as a result, there was a substantial risk that Hims &amp; Hers\u2019 collaboration with Novo Nordisk would be terminated.<\/li>\n<\/ul>\n<p align=\"justify\">The\u00a0Hims &amp; Hers\u00a0lawsuit further alleges that on June 23, 2025, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YCyeL_8RKtrB0XZ0FhMUuYbC-xr7g5KyeGs8KbUTndVRfj2SdeXrLBNHTM51UJrPTQZ_wOKn8VnCM0WCsBdgUWEbQscTKqN5rvHdrsgqs9X4hwwGYrb0LyT5FlR8Tue2cPbTEBfKbo7-_X-InGVFtLg3LauU0uRBePzNV1nI500TPW_weWrnND5BUHvuHzOaUrX_Xp3cHoP3Kwjw6fDvMzu5Q4m8f5tp81ZiCj0-jzZBuswfkliLHqfvdtOhyEsB1FLeoLdnA3yPygOTsUzaWijVnphUzW-XKm6GJAz-uaRO1qMXuv_-sixg7lBdOk6S2JO7oex84sE8cPRTncI9lROZmyh6reD9QVdgnT0SpbLIKeepnj99bN0Jp4WNo-PCaKPTU_eXSrWMskmRueY2z-ybBZRIFxZzwItxKNbnVEFW8K98gunWoo-aAB9h-z1d\" rel=\"nofollow\" target=\"_blank\">Novo Nordisk issued a press release announcing that it was terminating its partnership with Hims &amp; Hers<\/a><em>\u201cbased on Hims &amp; Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk.\u201d<\/em>\u00a0<\/p>\n<p align=\"justify\">On this news, the price of Hims &amp; Hers stock fell $18.26 per share, to close at $45.00 per share, a decline of more than 34%.<\/p>\n<p align=\"justify\">\n        <strong>DEADLINE<\/strong>: August 25, 2025. Shareholders should contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kNRJCDwc0Ob1mbDWLYLMRt9z2xbvvjJHp92mSFTLsY31nrhicfqOIl4rqGgt0-lMx1F_3KTmawDGmMs9Hg2wW2vpjxVJq5ljiF-22avsNm7LlzzC17GNgsMy8IaQuBsE4Pm4du6EhI8iE-bwAeQCDA==\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein<\/a> as soon as possible<\/p>\n<p>\n        <strong>Why\u00a0<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kNRJCDwc0Ob1mbDWLYLMRoE3wFonhuzsHHrGCIa3VHl7sDE-3kKQoRDQkUw37cbTOUcvgaaO8QaS0Vq9CsvO1rwXPzDEXwcF8DSxii9mI8uP7Tzd2tB95ikhdd7zyXm2bFwF8Cktx8Pf38xCLVjIkoDl8lWA5L_d3mbiS2X_WOqxMLtSVGjvp4BPssbO7t7Q\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <u>Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/u><br \/>\n          <\/strong><br \/>\n        <\/a><br \/>\n        <strong>?<\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p align=\"justify\">This illustrious <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QsE3Q4fS22b6xLvzhK6hWLH_TG6Lwf2P2Pm_YPdrsOfUuqidBgT1w5rG4N2TjRxrvvF_UJLXL_PmYzqShD06eMC0dRQTG2g15ngSoUOAx-pMki0LijHIHsUaGokGNR9h\" rel=\"nofollow\" target=\"_blank\">firm,<\/a> founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0The <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nCdUhRjw5roNTidfgM9y_R5pX0XX95L3_nDBKp623b4fe3PbW2NOk-aljTDhysBlmnULbFf0HLRVjzCSHZQQzPm64d5h1Y4yhZDveviubVsQqo5l59wJiYlATmQpenfB\" rel=\"nofollow\" target=\"_blank\">law firm\u00a0<\/a>brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p align=\"justify\">We encourage all investors who have been suffered losses or have information that will assist in our investigation, to contact\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kNRJCDwc0Ob1mbDWLYLMRoE3wFonhuzsHHrGCIa3VHl7sDE-3kKQoRDQkUw37cbT8UAxdqHfJU4-l5dom7ZSeHcCDaNtmdzYkCAX5B_9ZyaV72KZ_v79j4-o5Qu_CeVdV11Qj7Sem0hJ4shPPAEIRqWzjGtjkOFLwbI38yfJrHofMk0VCjenk05qplG_r7kj\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP.<\/a><\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Phone:<\/strong>\u00a0(800) 575-0735 or (212) 545-4774<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Email:\u00a0<\/strong><br \/>\n          <a href=\"mailto:classmember@whafh.com\" rel=\"nofollow\" target=\"_blank\">classmember@whafh.com<\/a>\n        <\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Contact Person:<\/strong>\u00a0<a href=\"mailto:gstone@whafh.com\" rel=\"nofollow\" target=\"_blank\">Gregory Stone, Director of Case and Financial Analysis<\/a><\/li>\n<\/ul>\n<p>\n        <strong>Firm Website:<\/strong>\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kNRJCDwc0Ob1mbDWLYLMRoE3wFonhuzsHHrGCIa3VHl7sDE-3kKQoRDQkUw37cbTmt8TxO5pARUnQ1Xx6vWOQLhBq0niuKipz6FCr_YUQerFxOZ63UBSHzfUWjXYY5dqw_Wy7DUWfRyBFRhuvZV9Cil_DIP8FWlBrp2vJtcBYSGuxIfxK0ODstoa175b_NTv\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a><\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OGE3NWFjY2ItYzZkZi00NzliLWFlZTMtMWI3MjZhZTlhZDUxLTEwMjkyNDItMjAyNS0wNy0wMi1lbg==\/tiny\/Wolf-Haldenstein-Adler-Freeman.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (\u201cHims &amp; Hers\u201d or the \u201cCompany\u201d) securities between April 29, 2025 and June 23, 2025, inclusive (the \u201cClass Period\u201d). Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the Firm prior to the August 25, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: Hims &amp; Hers is a telehealth company that provides prescription medications, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-866193","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (\u201cHims &amp; Hers\u201d or the \u201cCompany\u201d) securities between April 29, 2025 and June 23, 2025, inclusive (the \u201cClass Period\u201d). Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the Firm prior to the August 25, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: Hims &amp; Hers is a telehealth company that provides prescription medications, &hellip; Continue reading &quot;Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-02T15:52:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights\",\"datePublished\":\"2025-07-02T15:52:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/\"},\"wordCount\":457,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/\",\"name\":\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=\",\"datePublished\":\"2025-07-02T15:52:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/","og_locale":"en_US","og_type":"article","og_title":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk","og_description":"NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (\u201cHims &amp; Hers\u201d or the \u201cCompany\u201d) securities between April 29, 2025 and June 23, 2025, inclusive (the \u201cClass Period\u201d). Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the Firm prior to the August 25, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: Hims &amp; Hers is a telehealth company that provides prescription medications, &hellip; Continue reading \"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-02T15:52:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights","datePublished":"2025-07-02T15:52:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/"},"wordCount":457,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/","name":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=","datePublished":"2025-07-02T15:52:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODQ3NSM3MDI5ODk1IzIwMTc2NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending:\u00a0Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=866193"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866193\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=866193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=866193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=866193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}